Table 3.

Association between myocardial steatosis and serum cardiomyocyte-enriched miRNA in patients with uncomplicated type 2 diabetes.

	β	P-value		β	P-value
Model 1			Model 1
miR-1	0.360	0.006	miR-133a	0.335	0.008
Model 2			Model 2
miR-1	0.371	0.004	miR-133a	0.349	0.006
Age	0.229	0.069	Age	0.277	0.024
Visceral fat volume	0.139	0.277	Visceral fat volume	0.106	0.389
Non-HDL-cholesterol	0.233	0.156	Non-HDL-cholesterol	0.272	0.080
Plasma triglyceride	0.008	0.963	Plasma triglyceride	−0.045	0.775
Model 3			Model 3
Association between myocardial steatosis and serum miR-1 for model 2 and each of following variables:			Association between myocardial steatosis and serum miR-133a for model 2 and each of following variables:
i) Plasma fasting glucose	0.387	0.003	i) Plasma fasting glucose	0.352	0.006
ii) Plasma fasting insulin	0.370	0.004	ii) Plasma fasting insulin	0.355	0.006
iii) BMI	0.384	0.003	iii) BMI	0.349	0.007
iv) HDL-cholesterol	0.366	0.005	iv) HDL-cholesterol	0.346	0.007
v) Plasma NEFA	0.411	0.001	v) Plasma NEFA	0.355	0.007
vi) NT-proBNP	0.378	0.004	vi) NT-proBNP	0.349	0.007
vii) us-CRP	0.425	0.001	vii) us-CRP	0.401	0.002
viii) LV mass	0.351	0.009	viii) LV mass	0.337	0.009
ix) Ejection fraction	0.339	0.008	ix) Ejection fraction	0.333	0.009
x) E/Ea	0.413	0.005	x) E/Ea	0.385	0.006

Data are expressed as standardized beta (β).